Kent A Robertson

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. doi request reprint Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
    Kent A Robertson
    Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Lancet Oncol 13:1218-24. 2012
  2. doi request reprint Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromas
    Boaz Karmazyn
    Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Riley Hospital for Children, Indiana University Health, 705 Riley Hospital Drive, Rm 1053, Indianapolis, IN 46260, USA
    Pediatr Radiol 42:1218-22. 2012
  3. pmc Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis
    Melissa L Fishel
    Department of Pediatrics Section of Hematology Oncology, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 980 W Walnut, Indianapolis, IN 46202, USA
    Exp Hematol 38:1178-88. 2010
  4. pmc CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation
    Nandini Dey
    Section of Pediatric Hematology Oncology, Department of Pediatrics, AFLAC Cancer Center and Blood Disorders Services, Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30022, USA
    Mol Cell Biol 27:4179-97. 2007
  5. ncbi request reprint Serial transplantation resulting in tolerance to an unrelated cord blood graft
    W Scott Goebel
    Department of Pediatrics and the Pediatric Stem Cell Transplantation Program, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN 46202 5200, USA
    Transplantation 81:1596-9. 2006
  6. ncbi request reprint Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency disease
    Srilatha Atluri
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Pediatr Hematol Oncol 29:166-72. 2007
  7. ncbi request reprint Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia
    Franklin O Smith
    Division of Hematology Oncology, Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Br J Haematol 116:716-24. 2002

Research Grants

Collaborators

Detail Information

Publications7

  1. doi request reprint Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
    Kent A Robertson
    Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Lancet Oncol 13:1218-24. 2012
    ..We undertook an open-label phase 2 trial to test whether treatment with imatinib mesylate can decrease the volume burden of clinically significant plexiform neurofibromas in patients with NF1...
  2. doi request reprint Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromas
    Boaz Karmazyn
    Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Riley Hospital for Children, Indiana University Health, 705 Riley Hospital Drive, Rm 1053, Indianapolis, IN 46260, USA
    Pediatr Radiol 42:1218-22. 2012
    ..We observed bone marrow signal changes (BMSC) in patients with plexiform neurofibromas after treatment with imatinib mesylate (Gleevec)...
  3. pmc Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis
    Melissa L Fishel
    Department of Pediatrics Section of Hematology Oncology, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 980 W Walnut, Indianapolis, IN 46202, USA
    Exp Hematol 38:1178-88. 2010
    ....
  4. pmc CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation
    Nandini Dey
    Section of Pediatric Hematology Oncology, Department of Pediatrics, AFLAC Cancer Center and Blood Disorders Services, Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30022, USA
    Mol Cell Biol 27:4179-97. 2007
    ..We have elucidated a nongenomic extranuclear signal mediated by the RAR-SRC interaction that is negatively regulated by CSK and is required for RA-induced neuronal differentiation...
  5. ncbi request reprint Serial transplantation resulting in tolerance to an unrelated cord blood graft
    W Scott Goebel
    Department of Pediatrics and the Pediatric Stem Cell Transplantation Program, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN 46202 5200, USA
    Transplantation 81:1596-9. 2006
    ....
  6. ncbi request reprint Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency disease
    Srilatha Atluri
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Pediatr Hematol Oncol 29:166-72. 2007
    ..The clinical course of Epstein-Barr virus (EBV)-associated smooth muscle tumors is variable and there are no reports in patients with mixed T-cell chimerism after bone marrow transplantation (BMT)...
  7. ncbi request reprint Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia
    Franklin O Smith
    Division of Hematology Oncology, Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Br J Haematol 116:716-24. 2002
    ..With lower relapse observed in patients with chronic GVHD, new treatment strategies that focus on enhancing the graft-versus-leukaemia effect may improve survival...

Research Grants4

  1. APE EXPRESSION/LEUKEMIA RESPONSE TO CHEMO/RADIOTHERAPY
    Kent Robertson; Fiscal Year: 2001
    ....